Brain abscesses, neutropenia, and B-ALL: Multiple testing modalities required to confirm PDCD10 and ETV6 dual diagnoses.

Cytopenia Genetics Genome Germline Lymphoma Somatic

Journal

Cancer genetics
ISSN: 2210-7762
Titre abrégé: Cancer Genet
Pays: United States
ID NLM: 101539150

Informations de publication

Date de publication:
15 Aug 2024
Historique:
received: 03 05 2024
revised: 29 07 2024
accepted: 12 08 2024
medline: 24 8 2024
pubmed: 24 8 2024
entrez: 23 8 2024
Statut: aheadofprint

Résumé

Recognition of patients with multiple diagnoses, and the unique challenges they pose to clinicians and laboratorians, is increasing rapidly as genome-wide genetic testing grows in prevalence. We describe a unique patient with dual diagnoses of PDCD10-related cerebral cavernous malformations and ETV6-related thrombocytopenia with associated neutropenia. She presented with brain abscesses as an infant, which is highly atypical for these disorders in isolation. Confirming her diagnoses depended on thorough phenotyping both during and after her acute illness. Furthermore, the causative variant in ETV6 is a novel single-exon deletion that required multiple modalities with manual review to confirm, including unique use of polymorphic nucleotides in trio exome data. She illustrates the special challenges of patients with multiple diagnoses, and the multiple tools clinicians and laboratorians must use to treat them.

Identifiants

pubmed: 39178500
pii: S2210-7762(24)00037-1
doi: 10.1016/j.cancergen.2024.08.001
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-9

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest L.V., W.B., and N.O. are employed by Baylor Genetics in Houston, Texas. The remaining authors have no conflicts to disclose.

Auteurs

Runjun D Kumar (RD)

Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.

Liesbeth Vossaert (L)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics Laboratories, Houston, TX, USA.

Weimin Bi (W)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics Laboratories, Houston, TX, USA.

Nichole Owen (N)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics Laboratories, Houston, TX, USA.

Rachel E Rau (RE)

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

Hannah L Helber (HL)

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

Ghadir Sasa (G)

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

Jacquelyn Reuther (J)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Angshumoy Roy (A)

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA; Department of Pathology, Texas Children's Hospital, Houston, TX, USA.

Kevin E Fisher (KE)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA; Department of Pathology, Texas Children's Hospital, Houston, TX, USA. Electronic address: Kevin.Fisher@bcm.edu.

Classifications MeSH